Advisors Asset Management, Inc. Dynavax Technologies Corp Transaction History

Advisors Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$10.27 - $13.29 $1,376 - $1,780	-134 Reduced 12.97%	899 $9,000
Q3 2022 Nov 08, 2022	SELL	$9.93 - $17.44 $258 - $453	-26 Reduced 2.46%	1,033 $11,000
Q2 2022 Aug 08, 2022	SELL	$7.45 - $12.83 $9,707 - $16,717	-1,303 Reduced 55.17%	1,059 $13,000
Q1 2022 May 17, 2022	BUY	$9.75 - $14.44 $19,178 - $28,403	1,967 Added 497.97%	2,362 $26,000
Q4 2021 Feb 15, 2022	BUY	$13.17 - $20.94 $5,202 - $8,271	395 New	395 $6,000

275

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.63B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.